Kite Pharma, Inc.
KITE
KITE was delisted on the 2nd of October, 2017.
5 hedge funds and large institutions have $6.97M invested in Kite Pharma, Inc. in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$2.5M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.88M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.17M |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$1.11M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$529K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FCM
1
Frontier Capital Management
Boston,
Massachusetts
| $2.43M | +$2.5M | +83,960 | New |
|
|
2
Alyeska Investment Group
Chicago,
Illinois
| $1.82M | +$1.88M | +63,095 | New |
|
|
3
Citadel Advisors
Miami,
Florida
| $1.13M | +$1.17M | +39,138 | New |
|
|
EA
4
Emerald Advisers
Leola,
Pennsylvania
| $1.08M | +$1.11M | +37,250 | New |
|
|
EMFAT
5
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
| $513K | +$529K | +17,750 | New |
|
KITE Hedge Fund Activity: Q2 2014 in Review
5 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Kite Pharma, Inc. (KITE) for Q2 2014, worth a combined $6.97M.
Buyers outnumbered sellers: 5 funds opened new KITE positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Frontier Capital Management, opening a new position worth an estimated $2.5M.
- 5 institutional investors held Kite Pharma, Inc. (KITE) as of Q2 2014, up from 0 in Q1 2014.
- Funds reported $6.97M of Kite Pharma, Inc. stock for Q2 2014.
- 5 funds opened new Kite Pharma, Inc. positions in Q2 2014 and 0 closed out, a net change of +5 holders.
- The largest Kite Pharma, Inc. buyer in Q2 2014 was Frontier Capital Management, an estimated $2.5M added.
Based on aggregated 13F filings for Q2 2014.